eCAM Advance Access published online on April 25, 2006
eCAM, doi:10.1093/ecam/nel003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Glycoimmunotherapy, John Wayne Cancer Institute, Santa Monica, CA
* To whom correspondence should be addressed. The anticancer potential of catechins derived from green tea is not well understood, in part because catechin-related growth suppression and/or apoptosis appears to vary with the type and stage of malignancy as well as with the type of catechin. This in vitro study examined the biological effects of epicatechin (EC), epigallocatechin (EGC), EC 3-gallate (ECG) and EGC 3-gallate (EGCG) in cell lines from human gender-specific cancers. Cell lines developed from organ-confined (HH870) and metastatic (DU145) prostate cancer, and from moderately (HH450) and poorly differentiated (HH639) epithelial ovarian cancer were grown with or without EC, EGC, ECG or EGCG. When untreated cells reached confluency, viability and doubling time were measured for treated and untreated cells. Whereas EC treatment reduced proliferation of HH639 cells by 50%, EGCG suppressed proliferation of all cell lines by 50%. ECG was even more potent: it inhibited DU145, HH870, HH450 and HH639 cells at concentrations of 24, 27, 29 and 30 µM, whereas EGCG inhibited DU145, HH870, HH450 and HH639 cells at concentrations 89, 45, 62 and 42 µM. When compared with EGCG, ECG more effectively suppresses the growth of prostate cancer and epithelial ovarian cancer cell lines derived from tumors of patients with different stages of disease.
Received July 25, 2005
Accepted January 24, 2006
Original Article
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines
Mepur H. Ravindranath 1 *,
Thiruverkadu S. Saravanan 1,
Clarence C. Monteclaro 1,
Naftali Presser 1,
Xing Ye 1,
Senthamil R. Selvan 2,
and
Stanley Brosman 3
2 Cell Biology Laboratory, Hoag Cancer Center, Hoag Memorial Hospital Presbyterian, Newport Beach, CA
3 Pacific Clinical Research, Santa Monica, CA
Mepur H. Ravindranath, E-mail: Ravindranathm{at}jwci.org
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. H. Ravindranath, V. Ramasamy, S. Moon, C. Ruiz, and S. Muthugounder Differential Growth Suppression of Human Melanoma Cells by Tea (Camellia sinensis) Epicatechins (ECG, EGC and EGCG) Evid. Based Complement. Altern. Med., December 1, 2009; 6(4): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chatelain, S. Phippen, J. McCabe, C. A. Teeters, S. O'Malley, and K. Kingsley Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas Evid. Based Complement. Altern. Med., July 23, 2008; (2008) nen047v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Liang, C. W. Binns, L. Jian, and A. H. Lee Does the Consumption of Green Tea Reduce the Risk of Lung Cancer Among Smokers? Evid. Based Complement. Altern. Med., March 1, 2007; 4(1): 17 - 22. [Abstract] [Full Text] [PDF]
|
|